On October 15, UnitedHealth rose 3.04% in Regular Trading, trading at $406.79 per share, with turnover of $919 million.
The move follows a strong third-quarter report and supportive follow-up commentary from analysts and management. UnitedHealth reported adjusted EPS of $4.69 on revenue of $112.69 billion, both above market expectations, and lifted its full-year adjusted EPS outlook to at least $20.50 from a prior range of $19.50 to $20.00.
Subsequent commentary reinforced the positive readthrough: management said Medicaid margins are expected to bottom next year and improve through the following years, while also indicating consensus estimates for later-year earnings may be too low. Separately, Bernstein reiterated its rating and price target after the earnings beat, helping sustain positive sentiment around the stock.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments